Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

Author: van der Sandt I.C.J.   Blom-Roosemalen M.C.M.   de Boer A.G.   Breimer D.D.  

Publisher: Elsevier

ISSN: 0928-0987

Source: European Journal of Pharmaceutical Sciences, Vol.11, Iss.3, 2000-09, pp. : 207-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content